Skip to main content
Premium Trial:

Request an Annual Quote

David Botstein, Shirley Tilghman, James Broach, Stephen Fodor, Patrick Brown

Premium

David Botstein has been named as new director of Princeton University’s Lewis-Sigler Institute for Integrative Genomics. His appointment will start July 1 of next year. Botstein will succeed Shirley Tilghman, the founding director of the institute, who became president of the university last year, and James Broach, the institute’s interim director. Princeton established the genomics institute in 1999 and is now completing construction of a building for it, the Carl Icahn Laboratory. Botstein, who is a professor of genetics at Stanford University, received his bachelor’s degree from Harvard University and a doctoral degree from the University of Michigan, before teaching at the Massachusetts Institute of Technology from 1967 to 1988. He then served as vice president for science at Genentech for two years before joining the faculty at the Stanford School of Medicine. He is a member of the National Academy of Sciences and the Institute of Medicine and has received numerous awards.

Stephen Fodor, chairman, CEO, and co-founder of Affymetrix, was awarded the 2002 Innovator Award in the field of nanotechnology by The Economist last week, “for the invention and development of high-density DNA microarray technology.“ The prize follows on the heels of another one, the Takeda Award, which Fodor will be sharing with Patrick Brown of Stanford University.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.